Pulmonary Fibrosis

NOX4 implicated in fibrosis

Genkyotex, a developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in ...

Apr 11, 2014
popularity not rated yet | comments 0

Pulmonary fibrosis is the formation or development of excess fibrous connective tissue (fibrosis) in the lungs. It is also described as "scarring of the lung".

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News